Latest news

New research into the development of a potential new immunotherapy treatment for pancreatic cancer has been reported today in the media.

The National Institute for Health and Care Excellence (NICE) has today (Thursday, 17th September) announced it will not allow advanced pancreatic cancer patients in England routine access to the life-extending drug Abraxane on the NHS.

Research findings into the use of an anti-diabetic drug that can be used to ‘suffocate’ pancreatic cancer stem cells have been widely reported in the media today. Here's our comment.

NHS England has today (Friday, 4th September) announced that the life-extending drug Abraxane will no longer be available to people with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF) from 4th November 2015.

The Information Services Division (ISD) Scotland has this week released data showing trends in the likely number of cases of different cancer types over a 25 year period up until 2027. Here's our comment.